{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:22:47Z","timestamp":1793467367734,"version":"4.5.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100030732","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s40121-024-01077-z","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T12:01:31Z","timestamp":1732881691000},"page":"283-292","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Real-World Experience of Imipenem\u2013Relebactam Treatment as Salvage Therapy in Difficult-to-Treat Pseudomonas aeruginosa Infections (IMRECOR Study)"],"prefix":"10.1007","volume":"14","author":[{"given":"Isabel","family":"Machuca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arantxa","family":"Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Amaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Arjona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Gracia-Ahufinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maravillas","family":"Carralon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Giron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Gea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natividad","family":"De Benito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Galan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Antonio","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rayden","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaume","family":"Revuelto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Jose","family":"Caston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Ruiz-Arabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6091-4045","authenticated-orcid":false,"given":"Luis","family":"Mart\u00ednez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Torre-Cisneros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,29]]},"reference":[{"key":"1077_CR1","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1093\/cid\/ciy378","volume":"67","author":"SS Kadri","year":"2018","unstructured":"Kadri SS, Adjemian J, Lai YL, et al. Difficult-to-treat resistance in Gram-negative bacteremia at 173 US hospitals: retrospective cohort analysis of prevalence, predictors, and outcome of resistance to all first-line agents. Clin Infect Dis An Off Publ Infect Dis Soc Am. 2018;67:1803.","journal-title":"Clin Infect Dis An Off Publ Infect Dis Soc Am."},{"key":"1077_CR2","doi-asserted-by":"crossref","unstructured":"Sastre-Femenia M\u00c0, Fern\u00e1ndez-Mu\u00f1oz A, Gomis-Font MA, et al. Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis. Lancet Reg Heal Eur. 2023;34:100736","DOI":"10.1016\/j.lanepe.2023.100736"},{"key":"1077_CR3","doi-asserted-by":"crossref","unstructured":"Kaye KS, Boucher HW, Brown ML, et al. Comparison of treatment outcomes between analysis populations in the RESTORE-IMI 1 phase 3 trial of imipenem\u2013cilastatin\u2013relebactam versus colistin plus imipenem\u2013cilastatin in patients with imipenem-nonsusceptible bacterial infections. Antimicrob Agents Chemother. 2020;64(5):e02203\u201319","DOI":"10.1128\/AAC.02203-19"},{"key":"1077_CR4","doi-asserted-by":"publisher","first-page":"e4539","DOI":"10.1093\/cid\/ciaa803","volume":"73","author":"I Titov","year":"2021","unstructured":"Titov I, Wunderink RG, Roquilly A, et al. A randomized, double-blind, multicenter trial comparing efficacy and safety of imipenem\/cilastatin\/relebactam versus piperacillin\/tazobactam in adults with hospital-acquired or ventilator-associated bacterial pneumonia (RESTORE-IMI 2 Study). Clin Infect Dis An Off Publ Infect Dis Soc Am. 2021;73:e4539.","journal-title":"Clin Infect Dis An Off Publ Infect Dis Soc Am."},{"key":"1077_CR5","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour C, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:801.","journal-title":"JAMA."},{"key":"1077_CR6","unstructured":"CDC, Ncezid, DHQP. CDC\/NHSN Surveillance Definitions for Specific Types of Infections. 2024."},{"key":"1077_CR7","unstructured":"EUCAST: EUCAST [Internet]. [cited 2021 Mar 20]. Available from: https:\/\/eucast.org\/"},{"key":"1077_CR8","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1128\/JCM.00193-17","volume":"55","author":"VM Pierce","year":"2017","unstructured":"Pierce VM, Simner PJ, Lonsway DR, et al. Modified carbapenem inactivation method for phenotypic detection of carbapenemase production among Enterobacteriaceae. J Clin Microbiol. 2017;55:2321\u201333.","journal-title":"J Clin Microbiol."},{"key":"1077_CR9","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1093\/jac\/dkad062","volume":"78","author":"I Alonso-Garc\u00eda","year":"2023","unstructured":"Alonso-Garc\u00eda I, V\u00e1zquez-Ucha JC, Lasarte-Monterrubio C, et al. Simultaneous and divergent evolution of resistance to cephalosporin\/\u03b2-lactamase inhibitor combinations and imipenem\/relebactam following ceftazidime\/avibactam treatment of MDR Pseudomonas aeruginosa infections. J Antimicrob Chemother. 2023;78:1195\u2013200. https:\/\/doi.org\/10.1093\/jac\/dkad062.","journal-title":"J Antimicrob Chemother."},{"key":"1077_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab554","author":"N Rebold","year":"2023","unstructured":"Rebold N, Morrisette T, Lagnf AM, et al. Early Multicenter experience with imipenem\u2013cilastatin\u2013relebactam for multidrug-resistant Gram-negative infections. Open Forum Infect Dis. 2023. https:\/\/doi.org\/10.1093\/ofid\/ofab554.","journal-title":"Open Forum Infect Dis."},{"key":"1077_CR11","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S1473-3099(20)30796-9","volume":"21","author":"M Bassetti","year":"2021","unstructured":"Bassetti M, Echols R, Matsunaga Y, et al. Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial. Lancet Infect Dis. 2021;21:226\u201340.","journal-title":"Lancet Infect Dis."},{"key":"1077_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2023.106818","volume":"62","author":"C de la Fuente","year":"2023","unstructured":"de la Fuente C, Rodr\u00edguez M, Merino N, et al. Real-life use of cefiderocol for salvage therapy of severe infections due to carbapenem-resistant Gram-negative bacteria. Int J Antimicrob Agents. 2023;62: 106818.","journal-title":"Int J Antimicrob Agents"},{"key":"1077_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac097","author":"RK Shields","year":"2023","unstructured":"Shields RK, Stellfox ME, Kline EG, Samanta P, Van Tyne D. Evolution of imipenem\u2013relebactam resistance following treatment of multidrug-resistant pseudomonas aeruginosa pneumonia. Clin Infect Dis\u00ae. 2023. https:\/\/doi.org\/10.1093\/cid\/ciac097.","journal-title":"Clin Infect Dis\u00ae"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-024-01077-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-024-01077-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-024-01077-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T05:58:30Z","timestamp":1738216710000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-024-01077-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1077"],"URL":"https:\/\/doi.org\/10.1007\/s40121-024-01077-z","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,29]]},"assertion":[{"value":"12 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All named authors of this article confirm that they have nothing to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the Ethics Committee (code 5317) of Reina Sofia University Hospital, C\u00f3rdoba, Spain.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}